Technetium (99mTc) mertiatide explained

Drug Name:Technetium (99mTc) mertiatide
Width:200px
Tradename:Technescan Mag3
Dailymedid:Tc 99m mertiatide
Routes Of Administration:Intravenous
Atc Prefix:V09
Atc Suffix:CA03
Legal Us:Rx-only
Legal Us Comment:[1]
Kegg:D06039

Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. It is a renal imaging agent that is given by intravenous injection.

It was approved for medical use in the United States in June 1990.[2]

Medical uses

Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi.

Chemistry

The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide.

Notes and References

  1. Web site: Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution . DailyMed . 13 December 2022 . 1 February 2023 . 2 February 2023 . https://web.archive.org/web/20230202082803/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0571c18b-1d5e-47bd-bddf-54d74ce1b442 . live .
  2. Web site: Technescan Mag3: FDA-Approved Drugs . U.S. Food and Drug Administration (FDA) . 1 February 2023 . 13 December 2022 . https://web.archive.org/web/20221213225517/https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019882 . live .